GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving GTI-2040 together with capecitabine works in
treating patients with metastatic breast cancer. Drugs used in chemotherapy, such as
capecitabine, work in different ways to stop tumor cells from dividing so they stop growing
or die. GTI-2040 may help capecitabine kill more tumor cells by making them more sensitive to
the drug